Clinical Trial Update: A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing zolbetuximab plus chemotherapy versus placebo plus chemotherapy in adults with gastric and gastroesophageal junction adenocarcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Zolbetuximab (zolbetuximab)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-02-26